Supporting Information

Total Page:16

File Type:pdf, Size:1020Kb

Supporting Information Supporting Information Millay et al. 10.1073/pnas.1600101113 SI Materials and Methods GG-3′ and TMEM8a-R: 5′-TCAGGTCACTGTGTACAACTC-3′; Cell Culture and Primary Myoblast Isolation. C2C12 cells were and TMEM8b-F: 5′-ATGAACATGCCCCAGTCACTA-3′ and purchased from American Type Culture Collection and propa- TMEM8b-R: 5′-TCAGCTGACACAGATGCTGC-3′.Human gated in DMEM (Sigma) containing 10% heat-inactivated FBS and zebrafish myomaker cDNAs were synthesized by GenScript and supplemented with antibiotics; 10T1/2 fibroblasts were also and cloned into pBabe-X. purchased from American Type Culture Collection and passaged in the same media. C2C12 cells were differentiated by switching RNA Analysis. Total RNA was extracted from either mouse to media containing 2% heat-inactivated horse serum and antibiotics. tissue or cultured cells with TRIZOL (Invitrogen) and cDNA- All solutions described as a percentage are based on vol/vol. Primary synthesized using SuperScript III Reverse Transcriptase with LacZ/loxP myoblasts were isolated from myomaker ;Pax7-CreERT2 mice random hexamer primers (Invitrogen). Gene expression was after treatment with vehicle (WT) or five injections of tamoxifen assessed using standard quantitative PCR approaches with (KO) at a dose of 0.075 mg/g body weight. After dosing with either Power Sybr Green or Taqman Master Mix (Applied Bio- vehicle or tamoxifen, the gastrocnemius and tibialis anterior systems). Analysis was performed on a 7900HT Fast Real-Time were injured with cardiotoxin (10 μM; Sigma). Three days after PCR Machine (Applied Biosystems) with the following Sybr primers: Myomaker-F: 5′-ATCGCTACCAAGAGGCGTT-3′ injury, muscles were harvested and placed into gentleMACS C ′ ′ Tubes (Miltenyi Biotec) containing 2% collagenase (Type I; and Myomaker-R: 5 -CACAGCACAGACAAACCAGG-3 ; Tmem8a-F: 5′-CCAGCAACAGCAAGGAGAG-3′ and Tmem8a-R: Invitrogen) in low-glucose DMEM (Invitrogen). To dissociate 5′-GCTGCCATACCAGCTGTAGA-3′;andTmem8b-F:5′-TTAA- muscle, the C tubes were placed on a Miltenyi GentleMACS TGTCCGTGTGGGTCAC-3′ and Tmem8b-R: 5′-CAGAGCCAT- Dissociator and subjected to two cycles of digestion. Dispase AGACAGCAGCA-3′. As an internal control, 18S was used. (4.8 units/mL; Roche) was added to the digested muscle, in- cubated at 37 °C for 2 h, triturated using a pipette and 20-gauge μ Retroviral Generation and Cell Mixing. Ten micrograms of retroviral needle, passed through a 40- m filter, and centrifuged. The plasmid DNA was transfected using FuGENE 6 (Roche) into mononuclear cells were preplated for 20 min to remove non- Platinum E Cells (Cell Biolabs), which were plated on a 100-mm myoblast populations and then, plated on a collagen-coated plate culture dish at a density of 3 × 106 cells per dish 24 h before in growth media (20% FBS/Ham F10, 2.5 ng/mL bFGF; In- transfection. Forty-eight hours after transfection, viral media vitrogen). To enrich for myoblasts, cultures were incubated in a were collected, filtered through a 0.45-mm cellulose filter, and small volume of PBS, and the myoblasts were dislodged by mixed with Polybrene (Sigma) at a final concentration of 6 μg/mL. knocking the plate lightly. To induce myogenesis, the cultures For live staining experiments, C2C12 cells were plated on 35-mm were placed in differentiation media (2% horse serum, DMEM). culture dishes at a density of 1 × 105 cells per dish 24 h before infection with 3 mL viral media. Eighteen hours after infection, CRISPR-Mediated Genome Editing in C2C12 Cells. Freshly plated low- μ virus was removed, and cells were washed with PBS, which was passage C2C12 cells were transfected with 4 g pX330 (with replaced with differentiation media; 10T1/2 fibroblasts (∼50–60% myomaker guide RNA) and 4 μg pcDNA3-EGFP using 16 μL × 6 confluent on a 100-mm plate) were infected with 10 mL virus for Lipofectamine 2000. We transfected 1 10 C2C12 cells in a 18 h. After infection, cells were washed three times, trypsinized, 60-mm culture dish, and the medium was changed 16 h post- mixed with C2C12 cells at a 1:1 ratio (1.5 × 105 each cell type), transfection. Forty-eight hours after transfection, we sorted sin- + and plated on a 35-mm dish in 10% FBS and DMEM. The cul- gle GFP cells into 96-well plates using FACS. These cells were tures were differentiated the next day, and GFP and myosin ex- maintained in DMEM containing 20% FBS with antibiotics at pression were analyzed 4 d after differentiation. subconfluent densities. The cell lines were genotyped by ampli- fying a 435-bp region surrounding the predicted site of Cas9 RNA FISH. To detect myomaker expression at all stages of cell activity using the following primers: F: 5′-CAGTGCTGAG- differentiation, cultures were fixed (10 min at room temperature TCTGAAAGGGATA-3′ and R: 5′-TAAGCTCTGCAAAG- in 3.7% formaldehyde in PBS) at 24 h after seeding (day 0) and CAGCAAG-3′. This PCR product was then digested with NspI then, at 24-h intervals (days 1–3) followed by RNA FISH. After to genotype for editing of exon 2 of myomaker. An amplicon fixation, cells were washed twice with PBS and permeabilized in 70% from a WT clone (NspI site maintained) exhibited 317- and 118-bp ethanol for at least 1 h at 4 °C. Cells were subsequently incubated in bands after digestion, and an amplicon from a KO clone (NspI site Buffer A (2× SSC, 10% formamide) at room temperature for 5 min disrupted) remained at 435 bp. and then, hybridized with 125 nM probe in hybridization buffer (2× SSC, 10% formamide, 10% dextran sulfate) in humidified dark Cloning and Viral Infection. Each myomaker-FLAG construct was chambers at 37 °C for 16 h. After hybridization, cells were incubated generated by independently cloning the regions immediately in Buffer A for 30 min at 37 °C. Nuclei were stained with 6 ng/mL upstream (5′ PCR product) and downstream (3′ PCR product) Hoechst in Buffer A for 30 min at 37 °C. Cells were subsequently of the site of insertion and then, using these products in a standard incubatedin2× SSC at room temperature. Images were acquired PCR sewing reaction to generate full-length myomaker-FLAG within 5 h posthybridization with Nikon A1R+ LUNV on a Ti-E plasmids. The FLAG nucleotide sequence used was GATTA- Inverted Microscope. A set of probes specific to myomaker introns CAAGGATGACGACGATAAG, and for each internal FLAG with Quasar 570 Dye was designed using Stellaris Probe Designer, construct, we engineered a glycine–glycine–serine linker on both version 4.1 (Table S2). For GFP RNA FISH, commercially available sides of the epitope to aid in protein folding. The signal sequence Stellaris FISH Probe eGFP with Quasar 570 Dye was used. used upstream of FLAG was ATGAAGACGATCATCGCCC- TGAGCTACATCTTCTGCCTGGTGTTCGCC as previously Western Blot Analysis. Cells were washed two times with ice-cold described (27). TMEM8a was cloned from adult kidney cDNA, PBS and scraped into an Eppendorf tube. The cells were pelleted and TMEM8b was cloned from adult brain cDNA using the fol- and resuspended in lysis buffer (50 mM Tris·Cl,pH7.4,150mM lowing primers: TMEM8a-F: 5′-ATGGGCCGGGTTGGGGCCG- NaCl,1%TritonX-100,1%NonidetP-40,0.1%SDS).Protein Millay et al. www.pnas.org/cgi/content/short/1600101113 1of7 concentration was determined. and equal amounts (50 μg) were cubation with Alexa-Fluor secondary antibodies for 1 h. We used prepared with loading buffer [1× Laemmli (Bio-Rad) with 5% anti-mouse M2 Flag antibody (Sigma) at 1:500 and myosin an- β-mercaptoethanol]. Samples were incubated at room temper- tibody (MY32; Sigma) at 1:200. Nuclei were stained with Hoechst ature for 5 min (not boiled) and separated by 12% SDS/PAGE. (Invitrogen). For staining of live cells, we first washed the cells After SDS/PAGE, the gel was transferred to a PVDF membrane with PBS and incubated in blocking buffer (3% BSA/PBS) for Millipore), blocked in 5% milk in Tris-buffered saline (TBS)-Tween, 15 min. Primary antibody incubation was then performed on ice and incubated with M2 FLAG antibody (1:5,000; Sigma). GAPDH followed by fixation with 4% PFA/PBS and incubation with sec- (1:10,000; Millipore) was used as a loading control. We used a rabbit ondary antibody. These cultures were visualized on a Zeiss LSM anti-mouse secondary antibody conjugatedtoHRPfordetection. 780 Confocal Microscope. ImageJ was used to merge images. Immunocytochemistry. Immunocytochemistry was performed by Statistical Analyses. All data are presented as means with SEMs fixing cells with 4% paraformaldehyde (PFA)/PBS, permeabili- and were performed in replicates multiple times as indicated in zation with 0.2% Triton X-100 in PBS, blocking with 3% BSA/ the figures. P values were calculated using unpaired t test using PBS, incubation with primary antibody for at least 2 h, and in- GraphPad Prism 6 software. P < 0.05 was considered significant. Fig. S1. Genomic deletion of myomaker exon 2 after CRISPR/Cas 9 mutagenesis. A 435-bp fragment within exon 2 was amplified from genomic DNA from each myomaker KO clonal cell line and ligated into a shuttle vector (TOPO vector). Ten TOPO clones were then sequenced to identify the insertions or deletions after nonhomologous end joining (NHEJ) repair of the double-strand break. The missing nucleotides are indicated by dashes, and the total number of nu- cleotides disrupted is shown at the end of each line. For clones 1A3 and 1B1, the repair differed for each allele (displayed as A and B sequences). Sequencing of 10 TOPO clones from 1B5 showed the same sequence, suggesting identical repair of both alleles. Millay et al. www.pnas.org/cgi/content/short/1600101113 2of7 Fig. S2. Myomaker epitope-tagged constructs do not rescue fusion defect in myomaker KO myoblasts. (A) Myomaker KO myoblasts were infected with various myomaker-FLAG constructs and induced to differentiate.
Recommended publications
  • Supplemental Information to Mammadova-Bach Et Al., “Laminin Α1 Orchestrates VEGFA Functions in the Ecosystem of Colorectal Carcinogenesis”
    Supplemental information to Mammadova-Bach et al., “Laminin α1 orchestrates VEGFA functions in the ecosystem of colorectal carcinogenesis” Supplemental material and methods Cloning of the villin-LMα1 vector The plasmid pBS-villin-promoter containing the 3.5 Kb of the murine villin promoter, the first non coding exon, 5.5 kb of the first intron and 15 nucleotides of the second villin exon, was generated by S. Robine (Institut Curie, Paris, France). The EcoRI site in the multi cloning site was destroyed by fill in ligation with T4 polymerase according to the manufacturer`s instructions (New England Biolabs, Ozyme, Saint Quentin en Yvelines, France). Site directed mutagenesis (GeneEditor in vitro Site-Directed Mutagenesis system, Promega, Charbonnières-les-Bains, France) was then used to introduce a BsiWI site before the start codon of the villin coding sequence using the 5’ phosphorylated primer: 5’CCTTCTCCTCTAGGCTCGCGTACGATGACGTCGGACTTGCGG3’. A double strand annealed oligonucleotide, 5’GGCCGGACGCGTGAATTCGTCGACGC3’ and 5’GGCCGCGTCGACGAATTCACGC GTCC3’ containing restriction site for MluI, EcoRI and SalI were inserted in the NotI site (present in the multi cloning site), generating the plasmid pBS-villin-promoter-MES. The SV40 polyA region of the pEGFP plasmid (Clontech, Ozyme, Saint Quentin Yvelines, France) was amplified by PCR using primers 5’GGCGCCTCTAGATCATAATCAGCCATA3’ and 5’GGCGCCCTTAAGATACATTGATGAGTT3’ before subcloning into the pGEMTeasy vector (Promega, Charbonnières-les-Bains, France). After EcoRI digestion, the SV40 polyA fragment was purified with the NucleoSpin Extract II kit (Machery-Nagel, Hoerdt, France) and then subcloned into the EcoRI site of the plasmid pBS-villin-promoter-MES. Site directed mutagenesis was used to introduce a BsiWI site (5’ phosphorylated AGCGCAGGGAGCGGCGGCCGTACGATGCGCGGCAGCGGCACG3’) before the initiation codon and a MluI site (5’ phosphorylated 1 CCCGGGCCTGAGCCCTAAACGCGTGCCAGCCTCTGCCCTTGG3’) after the stop codon in the full length cDNA coding for the mouse LMα1 in the pCIS vector (kindly provided by P.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • A Chromosome Level Genome of Astyanax Mexicanus Surface Fish for Comparing Population
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.06.189654; this version posted July 6, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Title 2 A chromosome level genome of Astyanax mexicanus surface fish for comparing population- 3 specific genetic differences contributing to trait evolution. 4 5 Authors 6 Wesley C. Warren1, Tyler E. Boggs2, Richard Borowsky3, Brian M. Carlson4, Estephany 7 Ferrufino5, Joshua B. Gross2, LaDeana Hillier6, Zhilian Hu7, Alex C. Keene8, Alexander Kenzior9, 8 Johanna E. Kowalko5, Chad Tomlinson10, Milinn Kremitzki10, Madeleine E. Lemieux11, Tina 9 Graves-Lindsay10, Suzanne E. McGaugh12, Jeff T. Miller12, Mathilda Mommersteeg7, Rachel L. 10 Moran12, Robert Peuß9, Edward Rice1, Misty R. Riddle13, Itzel Sifuentes-Romero5, Bethany A. 11 Stanhope5,8, Clifford J. Tabin13, Sunishka Thakur5, Yamamoto Yoshiyuki14, Nicolas Rohner9,15 12 13 Authors for correspondence: Wesley C. Warren ([email protected]), Nicolas Rohner 14 ([email protected]) 15 16 Affiliation 17 1Department of Animal Sciences, Department of Surgery, Institute for Data Science and 18 Informatics, University of Missouri, Bond Life Sciences Center, Columbia, MO 19 2 Department of Biological Sciences, University of Cincinnati, Cincinnati, OH 20 3 Department of Biology, New York University, New York, NY 21 4 Department of Biology, The College of Wooster, Wooster, OH 22 5 Harriet L. Wilkes Honors College, Florida Atlantic University, Jupiter FL 23 6 Department of Genome Sciences, University of Washington, Seattle, WA 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.06.189654; this version posted July 6, 2020.
    [Show full text]
  • WO 2014/210448 Al 31 December 2014 (31.12.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/210448 Al 31 December 2014 (31.12.2014) P O P C T (51) International Patent Classification: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, A61K 45/00 (2006.01) C12N 15/09 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, A61K 48/00 (2006.01) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, (21) International Application Number: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, PCT/US2014/044554 OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (22) International Filing Date: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, 27 June 2014 (27.06.2014) TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of regional protection available): ARIPO (BW, GH, (30) Priority Data: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, 61/840,21 1 27 June 2013 (27.06.2013) US UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (71) Applicant: THE BOARD OF REGENTS OF THE UNI¬ EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, VERSITY OF TEXAS SYSTEM [US/US]; 201 W.
    [Show full text]
  • The Kinesin Spindle Protein Inhibitor Filanesib Enhances the Activity of Pomalidomide and Dexamethasone in Multiple Myeloma
    Plasma Cell Disorders SUPPLEMENTARY APPENDIX The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma Susana Hernández-García, 1 Laura San-Segundo, 1 Lorena González-Méndez, 1 Luis A. Corchete, 1 Irena Misiewicz- Krzeminska, 1,2 Montserrat Martín-Sánchez, 1 Ana-Alicia López-Iglesias, 1 Esperanza Macarena Algarín, 1 Pedro Mogollón, 1 Andrea Díaz-Tejedor, 1 Teresa Paíno, 1 Brian Tunquist, 3 María-Victoria Mateos, 1 Norma C Gutiérrez, 1 Elena Díaz- Rodriguez, 1 Mercedes Garayoa 1* and Enrique M Ocio 1* 1Centro Investigación del Cáncer-IBMCC (CSIC-USAL) and Hospital Universitario-IBSAL, Salamanca, Spain; 2National Medicines Insti - tute, Warsaw, Poland and 3Array BioPharma, Boulder, Colorado, USA *MG and EMO contributed equally to this work ©2017 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol. 2017.168666 Received: March 13, 2017. Accepted: August 29, 2017. Pre-published: August 31, 2017. Correspondence: [email protected] MATERIAL AND METHODS Reagents and drugs. Filanesib (F) was provided by Array BioPharma Inc. (Boulder, CO, USA). Thalidomide (T), lenalidomide (L) and pomalidomide (P) were purchased from Selleckchem (Houston, TX, USA), dexamethasone (D) from Sigma-Aldrich (St Louis, MO, USA) and bortezomib from LC Laboratories (Woburn, MA, USA). Generic chemicals were acquired from Sigma Chemical Co., Roche Biochemicals (Mannheim, Germany), Merck & Co., Inc. (Darmstadt, Germany). MM cell lines, patient samples and cultures. Origin, authentication and in vitro growth conditions of human MM cell lines have already been characterized (17, 18). The study of drug activity in the presence of IL-6, IGF-1 or in co-culture with primary bone marrow mesenchymal stromal cells (BMSCs) or the human mesenchymal stromal cell line (hMSC–TERT) was performed as described previously (19, 20).
    [Show full text]
  • Identification of Genomic Targets of Krüppel-Like Factor 9 in Mouse Hippocampal
    Identification of Genomic Targets of Krüppel-like Factor 9 in Mouse Hippocampal Neurons: Evidence for a role in modulating peripheral circadian clocks by Joseph R. Knoedler A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Neuroscience) in the University of Michigan 2016 Doctoral Committee: Professor Robert J. Denver, Chair Professor Daniel Goldman Professor Diane Robins Professor Audrey Seasholtz Associate Professor Bing Ye ©Joseph R. Knoedler All Rights Reserved 2016 To my parents, who never once questioned my decision to become the other kind of doctor, And to Lucy, who has pushed me to be a better person from day one. ii Acknowledgements I have a huge number of people to thank for having made it to this point, so in no particular order: -I would like to thank my adviser, Dr. Robert J. Denver, for his guidance, encouragement, and patience over the last seven years; his mentorship has been indispensable for my growth as a scientist -I would also like to thank my committee members, Drs. Audrey Seasholtz, Dan Goldman, Diane Robins and Bing Ye, for their constructive feedback and their willingness to meet in a frequently cold, windowless room across campus from where they work -I am hugely indebted to Pia Bagamasbad and Yasuhiro Kyono for teaching me almost everything I know about molecular biology and bioinformatics, and to Arasakumar Subramani for his tireless work during the home stretch to my dissertation -I am grateful for the Neuroscience Program leadership and staff, in particular
    [Show full text]
  • Continuously Active Transcriptional Programs Are Required to Build Expansive Serotonergic Axon Architectures
    CONTINUOUSLY ACTIVE TRANSCRIPTIONAL PROGRAMS ARE REQUIRED TO BUILD EXPANSIVE SEROTONERGIC AXON ARCHITECTURES By LAUREN JANINE DONOVAN Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Dissertation Advisor: Evan S. Deneris Department of Neurosciences CASE WESTERN RESERVE UNIVERSITY January 2020 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of Lauren Janine Donovan candidate for the degree of Doctor of Philosophy*. Committee Chair Jerry Silver, Ph.D. Committee Member Evan Deneris, Ph.D. Committee Member Heather Broihier, Ph.D. Committee Member Ron Conlon, Ph.D. Committee Member Pola Philippidou, Ph.D. Date of Defense August 29th, 2019 *We also certify that written approval has been obtained for any proprietary material contained therein. ii TABLE OF CONTENTS List of Figures……………………………………………………………………….….vii Abstract………………………………………….………………………………..….…1 CHAPTER 1. INTRODUCTION………………………………………………...……..3 GENERAL INTRODUCTION TO SEROTONIN………………………………….….4 Serotonin: Discovery and function………………………….……………...4 Serotonin Biosynthesis…………………………..…………………………..6 Manipulation of the serotonin system in humans……………………….6 Human mutations in 5-HT related genes………………………………….9 SEROTONIN NEURON NEUROGENESIS……………..………………………….11 5-HT neuron specification……………..………………………………...…11 Development of 5-HT neurons……………..………………………………13 NEUROANATOMY……………..……………………………………………………..13 Cytoarchitecture ……………..………………………………………………13 Adult Ascending 5-HT axon projection system ………………………..14
    [Show full text]
  • Association of Germline Variation with the Survival of Women with BRCA1/2 Pathogenic Variants and Breast Cancer ✉ Taru A
    www.nature.com/npjbcancer ARTICLE OPEN Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer ✉ Taru A. Muranen 1 ,Sofia Khan1,2, Rainer Fagerholm1, Kristiina Aittomäki3, Julie M. Cunningham 4, Joe Dennis 5, Goska Leslie 5, Lesley McGuffog5, Michael T. Parsons 6, Jacques Simard 7, Susan Slager8, Penny Soucy7, Douglas F. Easton 5,9, Marc Tischkowitz10,11, Amanda B. Spurdle 6, kConFab Investigators*, Rita K. Schmutzler12,13, Barbara Wappenschmidt12,13, Eric Hahnen12,13, Maartje J. Hooning14, HEBON Investigators*, Christian F. Singer15, Gabriel Wagner15, Mads Thomassen16, Inge Sokilde Pedersen 17,18, Susan M. Domchek19, Katherine L. Nathanson 19, Conxi Lazaro 20, Caroline Maria Rossing21, Irene L. Andrulis 22,23, Manuel R. Teixeira 24,25, Paul James 26,27, Judy Garber28, Jeffrey N. Weitzel 29, SWE-BRCA Investigators*, Anna Jakubowska 30,31, Drakoulis Yannoukakos 32, Esther M. John33, Melissa C. Southey34,35, Marjanka K. Schmidt 36,37, Antonis C. Antoniou5, Georgia Chenevix-Trench6, Carl Blomqvist38,39 and Heli Nevanlinna 1 Germline genetic variation has been suggested to influence the survival of breast cancer patients independently of tumor pathology. We have studied survival associations of genetic variants in two etiologically unique groups of breast cancer patients, the carriers of germline pathogenic variants in BRCA1 or BRCA2 genes. We found that rs57025206 was significantly associated with the overall survival, predicting higher mortality of BRCA1 carrier patients with estrogen receptor-negative breast cancer, with a hazard ratio 4.37 (95% confidence interval 3.03–6.30, P = 3.1 × 10−9). Multivariable analysis adjusted for tumor characteristics suggested that rs57025206 was an independent survival marker.
    [Show full text]
  • Myoblast Fusion Confusion: the Resolution Begins Srihari C
    Sampath et al. Skeletal Muscle (2018) 8:3 DOI 10.1186/s13395-017-0149-3 REVIEW Open Access Myoblast fusion confusion: the resolution begins Srihari C. Sampath1,2*, Srinath C. Sampath1,2* and Douglas P. Millay3,4* Abstract The fusion of muscle precursor cells is a required event for proper skeletal muscle development and regeneration. Numerous proteins have been implicated to function in myoblast fusion; however, the majority are expressed in diverse tissues and regulate numerous cellular processes. How myoblast fusion is triggered and coordinated in a muscle-specific manner has remained a mystery for decades. Through the discovery of two muscle-specific fusion proteins, Myomaker and Myomerger–Minion, we are now primed to make significant advances in our knowledge of myoblast fusion. This article reviews the latest findings regarding the biology of Myomaker and Minion–Myomerger, places these findings in the context of known pathways in mammalian myoblast fusion, and highlights areas that require further investigation. As our understanding of myoblast fusion matures so does our potential ability to manipulate cell fusion for therapeutic purposes. Keywords: Myoblast fusion, Myomaker, Myomerger, Minion, Muscle development Background and therefore, methods to dominantly reconstitute fusion Muscle formation occurs during several stages of an organ- and dissect its mechanisms were nonexistent. ism’s life, including embryonic development, and growth Plasma membrane fusion is a complex process that re- and regeneration in the adult. Proper myogenesis begins quires recognition, adhesion, cell signaling, cytoskeletal al- through specification of precursor cells to the myoblast terations, and membrane rearrangements. Current lineage, followed by differentiation, both of which are evidence, reviewed elsewhere, implicates numerous pro- accomplished by the muscle-specific transcription factors teins and regulatory pathways in the recognition, adhesion, MyoD and Myogenin [1, 2].
    [Show full text]
  • UC Merced Electronic Theses and Dissertations
    UC Merced UC Merced Electronic Theses and Dissertations Title High-throughput Analysis of WNT Signaling Pathway in Osteoblasts Permalink https://escholarship.org/uc/item/8b48d5hn Author Sebastian, Aimy Publication Date 2016 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, MERCED High-throughput Analysis of WNT Signaling Pathway in Osteoblasts A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Quantitative and Systems Biology by Aimy Sebastian Committee in charge: Dr. Suzanne S. Sindi, Chair Dr. David H. Ardell Dr. Gabriela G. Loots Dr. Jennifer O. Manilay 2016 Copyright Aimy Sebastian, 2016 All rights reserved The Dissertation of Aimy Sebastian is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Gabriela G. Loots Jennifer O. Manilay David H. Ardell Suzanne S. Sindi, Chair Date University of California, Merced 2016 iii Table of Contents Signature Page ..................................................................................................................... iii Table of Contents ................................................................................................................. iv List of Figures ...................................................................................................................... vi List of Tables ....................................................................................................................
    [Show full text]
  • Supplementary Information
    SUPPLEMENTARY INFORMATION 1. SUPPLEMENTARY FIGURE LEGENDS Supplementary Figure 1. Long-term exposure to sorafenib increases the expression of progenitor cell-like features. A) mRNA expression levels of PROM-1 (CD133), THY-1 (CD90), EpCAM, KRT19, and VIM assessed by quantitative real-time PCR. Data represent the mean expression value for a gene in each phenotypic type of cells, displayed as fold-changes normalized to 1 (expression value of its corresponding parental non-treated cell line). Expression level is relative to the GAPDH gene. Bars indicate standard deviation. Significant statistical differences are set at p<0.05. B) Immunocitochemical staining of CD90 and vimentin in Hep3B sorafenib resistant cell line and its parental cell line. C) Western blot analysis comparing protein levels in resistant Hu6 and Hep3B cells vs their corresponding parental cells lines. Supplementary Figure 2. Efficacy of gene silencing of IGF1R and FGFR1 and evaluation of MAPK14 signaling activation. IGF1R and FGFR1 knockdown expression 48h after transient transfection with siRNAs (50 nM), in non-treated parental cells and sorafenib-acquired resistant tumor derived cells was assessed by quantitative RT-PCR (A) and western blot (B). C) Activation status of MAPK14 signaling was evaluated by western blot analysis in vivo, in tumors with acquired resistance to sorafenib in comparison to non-treated tumors (right panel), as well as in in vitro, in sorafenib resistant cell lines vs parental non-treated. Supplementary Figure 3. Gene expression levels of several pro-angiogenic factors. mRNA expression levels of FGF1, FGF2, VEGFA, IL8, ANGPT2, KDR, FGFR3, FGFR4 assessed by quantitative real-time PCR in tumors harvested from mice.
    [Show full text]
  • Systems Genetics in Polygenic Autoimmune Diseases
    From the Institute of Experimental Dermatology Director: Prof. Saleh Ibrahim Systems genetics in polygenic autoimmune diseases Dissertation for Fulfillment of Requirements for the Doctoral Degree of the University of Lübeck from the Department of Medicine Submitted by Yask Gupta from New-Delhi, India Lübeck 2015 i First referee:- Prof. Dr. med Saleh Ibrahim Second referee:- Prof. Dr. rer. nat. Jeanette Erdman Chairman:- Prof. Dr. Horst-Werner Stüzbecher Data of oral examination:- 7 June 2016 ii iii Contents 1. Introduction 9 1.1 Autoimmune diseases 3 1.2 Autoimmune bullous diseases 4 1.3 Epidermolysis bullosa acquisita (EBA): an autoantibody-mediated autoimmune skin disease 5 1.4 Role of miRNA in autoimmune diseases 5 1.5 Genes in autoimmune diseases 7 1.6 Gene networks 8 1.6.1 Gene/Protein interaction database 9 1.6.2 Ab intio prediction of gene networks 11 1.7 QTL and expression QTL 12 1.8. Prediction of ncRNA 13 1.8.1 Support vector machine and random forest 15 1.9. Structure of the thesis 18 2. Aims of the thesis 21 3. Materials and methods 23 3.1 Generation of a four way advanced intercross line 23 iv 3.2 Experimental EBA and observation protocol 24 3.2.1 Generation of recombinant peptides 24 3.3 Extraction of genomic DNA for genotypic analysis 25 3.4 Generation of microarray data (miRNAs/genes) and bioinformatics analysis 25 3.5 Software for Expression QTL analysis 26 3.5.1 HAPPY 27 3.5.2 EMMA 28 3.5.3 Implementation of software for expression QTL mapping 30 3.6 Ab initio Gene and microRNAs networks prediction 31 3.6.1 MicroRNAs 32 3.6.2 Genes 33 3.6.3 MicroRNAs gene target prediction 34 3.7 Visualization of interaction networks 35 3.8 Network databases (STRING and IPA) 36 3.9 Prediction of ncRNA tools 37 3.9.1 Dataset 38 3.9.2 Features for classification 39 3.9.3 Classification system 41 v 3.9.4 Implementation of support vector machines and random forest on the post transcriptional non coding RNA dataset 42 3.9.5 Work flow and output of ptRNApred 45 4.
    [Show full text]